The Protective Effects of Lactoferrin Feeding against Endotoxin Lethal Shock in Germfree Piglets

Infection and Immunity

Volumn 66, Issue 4, 1998, Pages 1421-1426

  Lee, Wang J ^a,c   Farmer, Jeffrey L ^b   Hilty, Milo ^b   Kim, Yoon B ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; BODY TEMPERATURE; DRUG EFFECT; FLOW CYTOMETRY; GERMFREE ANIMAL; METABOLISM; MONOCYTE; SEPTIC SHOCK; SWINE;

ANIMALS; BODY TEMPERATURE; FLOW CYTOMETRY; GERM-FREE LIFE; LACTOFERRIN; LIPOPOLYSACCHARIDES; MONOCYTES; SHOCK, SEPTIC; SWINE;

EID: 0032038664     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.4.1421-1426.1998     Document Type: Article

References (32)

1. Appelmelk, B. J., Y.-Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62:2628-2632.
2. Arnold, R. R., M. Brewer, and J. J. Gauthier. 1980. Bacterial activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 28:893-898.
3. Arnold, R. R., J. E. Russell, W. J. Champion, and J. J. Gauthier. 1981. Bactericidal activity of human lactoferrin: influences of physical conditions and metabolic state of the target microorganisms. Infect. Immun. 32:655-660.
4. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
5. Britigan, B. E., J. S. Serody, and M. S. Cohen. 1994. The role of lactoferrin as an anti-inflammatory molecule. Adv. Exp. Med. Biol. 357:143-156.
6. Bullen, J. J., H. J. Rogers, and E. Griffiths. 1978. Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80:1-35.
7. Elass-Rochard, E., A. Roseanu, D. Logrand, M. Trif, V. Salmon, C. Motas, J. Montreuil, and G. Spik. 1995. Luctoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312:839-845.
8. Ellison, R. T., III, and T. J. Giehl. 1991. Killing of gram-negative bacteria by lactoferrin and lysozymes. J. Clin. Invest. 88:1080-1091.
9. Farmer, J. L., and L. Roberts. Unpublished data.
10. Gutteberg, T. J., O. Rokke, O. Anderson, and T. Joergensen. 1989. Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: an early defence mechanism. Scand. J. Infect. Dis. 21:708-715.
11. Kim, Y. B., and D. W. Watson. 1965. Modification of host responses to bacterial endotoxins. II. Passive transfer of immunity to bacterial endotoxin with fractions containing 19S antibodies. J. Exp. Med. 121:751-759.
12. Kim, Y. B., and D. W. Watson. 1966. Role of antibodies in reactions to gram-negative bacterial endotoxins. Ann. N. Y. Acad. Sci. 133:727-745.
13. Kim, Y. B., and D. W. Watson. 1967. Biologically active endotoxin from salmonella mutants deficient in O-and R-polysaccharides and heptose. J. Bacteriol. 94:1320-1326.
14. Kim, Y. B. 1975. Developmental immunity in the piglet, p. 549-557. In D. Bergsma, R. A. Good, and J. Finnstad (ed.), Immunodeficiency in man and animals. Birth defects: original articles series, vol. XI (no. 1). Sinauer Associatcs, Inc., Sunderland, Mass.
15. Machnicki, M., M. Zimecki, and T. Zagulski. 1993. Lactoferrin regulates the release of tumor necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74:433-439.
16. Mattsby-Baltzer, I., A. Roseanu, C. Motas, J. Elverfors, I. Engberg, and L. A. Hanson. 1996. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40: 157-262.
17. Mehrazar, K., A. Gilman-Sachs, and Y. B. Kim. 1993. Intestinal absorption of immunologically intact macromolecules in germfree colostrum-deprived piglets maintained on total parenteral nutrition. J. Parenter. Enteral. Nutr. 17:8-15.
18. Miyazawa, K., C. Mantel, L. Lu, D. C. Morrison, and H. E. Broxymeyer. 1991. Lactoferrin-lipopolysaccharide interactions: effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol. 146: 723-729.
19. Naidu, S. S., U. Svensson, A. R. Kishore, and A. S. Naidu. 1993. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob. Agents Chemother. 37:240-245.
20. Nitsche, D. August 1993. Use of lactoferrin for treatment of toxic effect of endotoxins. U.S. patent 5,240,909, p. 1-16.
21. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477.
22. Schotanus, K., G. M. Holtkamp, N. Van Rooijen, F. J. M. Tilders, and F. Berkenbosch. 1995. Circulating tumor necrosis factor-α does not mediate endotoxin-induced hypothermia in rats. Am. J. Physiol. 168:R989-R996.
23. Tokhard, S., A. S. Hare, D. J. Nutt, and G. Clarke. 1996. TNFα mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain. Neuropharmacology 35:243-248.
24. Tracey, K. J., and A. Cerami. 1987. Cachectin/tumor necrosis factor and other cytokines in infectious disease. Curr. Opin. Immunol. 1:454-461.
25. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169:333-338.
26. Wang, C.-S., W.-Y. Chan, and H. U. Kloer. 1984. Comparative studies on the chemical and immunochemical properties of human milk, human pancreatic juice and bovine milk lactoferrin. Comp. Biochem. Physiol. 788:575-580.
27. Wang, D., K. M. Pabst, Y. Aida, and M. J. Pabst. 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukocyte Biol. 57:865-874.
28. Watson, D. W., and Y. B. Kim. 1963. Modification of host responses to bacterial endotoxins. I. Specificity of pyrogenic tolerance and the role of hypersensitivity in pyrogenicity, lethality, and skin reactivity. J. Exp. Med. 118:425-446.
29. Weinberg, E. D. 1978. Iron and infection. Microbiol. Rev. 42:45-66.
30. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
31. Zagulski, T., P. Lipinski, A. Zagulska, S. Broniek, and C. Morse. 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70:697-704.
32. Ziegler, E. J., C. J. Fisher, Jr., C. L. Sprung, et al. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N. Engl. J. Med. 324:429-436.